Model
Edge
Relmada Therapeutics, Inc.
RLMD
Filing Type
S-8
Filing Date
6/17/2026
Updated
6/18/26, 2:05 PM
Copy Ref
Filing
S-8
Earnings Release
Exhibits
S-8
Registration Statement for Securities to be Offered to Employees
EX-5.1
OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP
EX-23.1
CONSENT OF CBIZ CPAS P.C
EX-23.2
CONSENT OF MARCUM LLP
EX-99.4
RELMADA THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN, AS AMENDED
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic
GRAPHIC
Graphic